Halogenated Nucleosides
5'-Deoxy-5-fluoro-N4-[(2-methylbutoxy)carbonyl]-cytidine
Quick view. We supply 5'-Deoxy-5-fluoro-N4-[(2-methylbutoxy)carbonyl]-cytidine as a halogenated nucleoside analog for modified nucleoside, antiviral/antimetabolite and oligonucleotide precursor research. CAS 910129-15-6. Catalog target purity: Specification on request.
![Chemical structure of 5'-Deoxy-5-fluoro-N4-[(2-methylbutoxy)carbonyl]-cytidine](/structures/84276e9f19c35c09.svg)
Product profile
5'-Deoxy-5-fluoro-N4-[(2-methylbutoxy)carbonyl]-cytidine is classified as nucleoside or protected nucleoside intermediate (Formula C15H22FN3O6; molecular weight 359.35).
5'-Deoxy-5-fluoro-N4-[(2-methylbutoxy)carbonyl]-cytidine can serve as a starting material, protected intermediate or analytical comparator in nucleoside and nucleotide route development.
For 5'-Deoxy-5-fluoro-N4-[(2-methylbutoxy)carbonyl]-cytidine, reported solubility: Chloroform (Slightly), Methanol (Slightly). Storage: Sealed in dry,2-8°C.
Names and search terms
Confirmed or normalized name variants
- 5'-deoxy-5-fluoro-N4-(2-methyl-1-butyloxycarbonyl)cytidine
- CS-936
- Capecitabine-4
- Capecitabin iMpurity F
- Capecitabine iMpurity E
- Capecitabine EP Impurity D
- Capecitabine 2-Methylbutyloxy Imp
- Capecitabine 2-Methylbutyloxy Impurity
Useful catalog search terms
- CAS 910129-15-6
- Nucleoside or protected nucleoside intermediate
- Halogenated Nucleosides
Physicochemical data
| InChI | InChI=1S/C15H22FN3O6/c1-4-7(2)6-24-15(23)18-12-9(16)5-19(14(22)17-12)13-11(21)10(20)8(3)25-13/h5,7-8,10-11,13,20-21H,4,6H2,1-3H3,(H,17,18,22,23)/t7?,8-,10-,11-,13-/m1/s |
|---|---|
| InChIKey | WBAXSXXYPPILCT-DGHYOTGBSA-N |
| SMILES | FC1=CN(C(=O)N=C1NC(=O)OCC(CC)C)[C@@H]2O[C@@H]([C@H]([C@H]2O)O)C |
| Melting point | 62-64°C |
| Form | Solid |
| Color | White to Off-White |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Additional application examples
- Typical work includes protection/deprotection studies, phosphorylation or phosphitylation route scouting and impurity identification.
- The material can support medicinal-chemistry analog preparation and process-development feasibility studies.
Product-specific evaluation notes
Potential advantages
- 2′-fluoro motifs can improve nuclease resistance while preserving RNA-like geometry in many sequence contexts.
Method limitations
- Coupling, deprotection and biological performance remain sequence- and position-dependent.
These points describe 5'-Deoxy-5-fluoro-N4-[(2-methylbutoxy)carbonyl]-cytidine or its named chemical feature. Broader product-family guidance is maintained on the category page.
Related products
2'-5-CF3-dU
Halogenated Nucleosides · CAS: 70-00-8
BX-HN-00026-Cl-purine-2'-deoxyriboside
Halogenated Nucleosides · CAS: 4594-45-0
BX-HN-00038-Cl-2'-dA
Halogenated Nucleosides · CAS: 85562-55-6
BX-HN-00042'-Chloro-2'-deoxycytidine
Halogenated Nucleosides · CAS: 10212-19-8
BX-HN-00055-bromo-2'-deoxycytidine
Halogenated Nucleosides · CAS: 1022-79-3
BX-HN-00065-Iodouridine
Halogenated Nucleosides · CAS: 1024-99-3
Frequently asked questions
Can the package size for 5'-Deoxy-5-fluoro-N4-[(2-methylbutoxy)carbonyl]-cytidine be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-HN-0261 and CAS 910129-15-6, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
The publications below provide peer-reviewed context for the Halogenated Nucleosides product family and its named chemistry.